Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy.
Saved in:
| Title: | Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy. |
|---|---|
| Authors: | DuPont HL; Internal Medicine, University of Texas School of Public Health, Houston, TX 77030, USA., Almenoff JS; Department of Medical Affairs, Redhill Biopharma Inc., Raleigh, NC 27617, USA., Jamindar MS; Department of Medical Affairs, Redhill Biopharma Inc., Raleigh, NC 27617, USA., Bortey E; Pharmaceutical Development Strategies LLC, Chapel Hill, NC 27517, USA., Steffen R; Department of Epidemiology, University of Zurich, 8001 Zurich, Switzerland. |
| Source: | Journal of travel medicine [J Travel Med] 2023 Oct 31; Vol. 30 (6). |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9434456 Publication Model: Print Cited Medium: Internet ISSN: 1708-8305 (Electronic) Linking ISSN: 11951982 NLM ISO Abbreviation: J Travel Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
